Invention Grant
US09045562B2 Compositions and methods for modulating lymphocyte activity 有权
用于调节淋巴细胞活性的组合物和方法

Compositions and methods for modulating lymphocyte activity
Abstract:
The present invention provides a novel lymphocyte inhibitory receptor termed BTLA which is expressed on both T and B cells, and identifies HVEM as interacting with BTLA. Methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM for therapeutic, diagnostic and research purposes are also provided.
Public/Granted literature
Information query
Patent Agency Ranking
0/0